Runway Growth Capital Adds to Life Sciences Team with New Managing Director in Dallas » Dallas Innovates

Runway Growth Capital, a California-based provider of growth loans to venture-backed companies and not looking for an alternative to raising equity, announced that it has hired Brannon Morisoli as Managing Director, life sciences.

Operating out of Dallas, Morisoli will continue to build relationships with leading venture capital firms that support life science management teams, while expanding the company’s banking and brokerage relationships. Runway’s industry partners include venture capital firms, private equity firms, and investment and commercial banks.

Debt Capital Solutions for Life Sciences Companies

Morisoli will focus on investments in the life sciences industry, structuring flexible debt capital solutions for borrowers that will allow them to stay focused on achieving their business goals, Runway said in a statement.

The life sciences ecosystem is complex, the company notes. It is therefore important to understand the difficult journey from concept to commercialization.

Fueling Life Sciences with Low Dilutive Venture Capital Debt

Runway Growth Capital, whose slogan is “the other growth capital”, seeks life sciences companies at the forefront of clinical development and innovation in the field of health care, those which advance treatments and improve patient outcomes.

Its capital can help companies focus on those results, Runway says. A typical loan amount is $10 million to $75 million, and proceeds are typically used to expand runway, fuel growth, refinance other debt and fund acquisitions, according to the company.

Morisoli will report directly to General Manager of Life Sciences, Igor DaCruz.

“Life sciences continue to be an important focus area for Runway. Brannon’s industry expertise, creative experience and extensive life sciences network make him an ideal candidate to continue to grow the practice,” DaCruz said in a statement.

Morisoli will be responsible for “identifying life sciences companies that can benefit from debt to strengthen their balance sheets and fuel their growth,” the life sciences director said.

Morisoli joins life sciences team amid boom in DFW

Morisoli was attracted to Runway for its “rapid growth, strong brand and reputation as a great partner,” he said, noting the strong foundation in place for life sciences. He joins the life sciences team at a time when life sciences are booming in North Texas. Most recently, Dallas-Fort Worth ranked for the first time in CommercialEdge’s 2022 “Top 20 US metros for life science” report.

Morisoli was previously a director of SWK Holdings, where he focused on providing innovative capital solutions to a wide range of healthcare and life sciences companies.

Previously, he was an investment analyst for Presidium Group, where he played a key role in the closing of $100 million in transactions for the real estate private equity fund.

Morisoli, an industry veteran with a working knowledge of the life sciences and medical device space, began his career as a research associate where he was published in leading neurology journals. He also gained operational experience as director of marketing services at Neurografix, a venture capital-backed medical technology start-up.

Boston’s chief technology officer also named

Beyond life sciences, Runway Growth Capital also serves the technology and consumer industries.

The company also announced a new Chief Technology Officer. Ted Cavan will operate out of Boston and also report to DaCruz. Cavan will work with late-stage and growth-stage technology companies, focusing on enterprise software, according to the company.

Partner of entrepreneurs

Runway Growth Capital LLC, founded in 2015 by an industry veteran David Spreng, is an investment advisor to investment funds. According to the company, these include Runway Growth Finance Corp. (Nasdaq: RWAY), a business development company, and other private funds that lend growth capital to companies that want an alternative to fundraising.

Runway works with fast growing companies based in United States and Canada. Since its inception, the company has financed 61 companies and has made loan commitments of $1.8 billion to date.

Quincy Preston contributed to this report.

Join the list.
Dallas innovates, every day.

Sign up to keep an eye on what’s new and coming to Dallas-Fort Worth, every day.

READ NEXT

  • Vision2 Systems, a fast-growing online giving platform designed for churches, will use the $2.8 million investment for its expansion.

  • The summit is an innovation multiplier for capital, collaboration and commercialization. Plus, you can meet NTX 2021 rising stars and new companies moving into Pegasus Park BioLabs. Here is an updated schedule for the annual iC3 Life Sciences Summit on September 30 and October 1.

  • Two nonprofit organizations will each receive $250,000 in grants. The Capital One grants are part of a $3.5 million commitment to 12 nonprofit organizations.

  • In this week‘s roundup of North Texas hires, promotions and accolades, you’ll also find news from Firehouse, Enseo, Cambium Learning, D Magazine, Lear Investment Management, Spacee, Envy Gaming, 5Q, Stream Realty Partners, Nanoscope, Crossplane Capital, Enhancement, TimelyMD and more.

  • The application deadline is Friday, September 17. The 2021 award, sponsored by BioLabs at Pegasus Park, will be presented Sept. 30 at the iC3 Life Science Summit. The impact that Dr. Dennis K. Stone has left on the DFW biotechnology industry is, without a doubt, immeasurable, says BioNTX. Past recipients of the award honoring her memory are Phil Ralston, Lyda Hill, Darlene Boudreaux, Paul Dorman and Hubert Zajicek.

Comments are closed.